The prevalence of T2D (21.0% vs. 29.1%, p < 0.027) and obesity (18.6% vs. 27.6%, p < 0.019) was significantly lower in patients with elevated Lp(a) than in participants without elevated Lp(a) (Supplementary Table 2a and b). This evidence concerns the gene LPA and obesity due to melanocortin 4 receptor deficiency.